RecruitingNot ApplicableNCT04811313

Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy

Impact of Tranexamic Acid Use on Blood Loss and Transfusion Rates After Hip Reconstruction in Children, A Randomized Controlled Trial


Sponsor

Assiut University

Enrollment

400 participants

Start Date

Apr 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Surgical hip reconstruction reduces the hip joint through soft tissue releases and osteotomies of the femur and/or pelvis. Blood loss and subsequent blood transfusion are normal consequences of hip reconstruction.


Eligibility

Min Age: 1 YearMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo, a drug called Tranexamic acid, and others for people with intraoperative blood loss., orthopedic disorder, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Year to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTranexamic acid

patients treated with TXA will have reduced blood loss and transfusion requirements compared with those who did not receive TXA

PROCEDUREcaudal epidural block

regional anesthesia in orthopedic procedures are known to help reduction of intraoperative blood loss

OTHERPlacebo

participants will receive standard care but neither TXA nor caudal epidural block


Locations(1)

Assiut University

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04811313


Related Trials